FDA official logo
GSRS logo
PFDA official logo

TRASTUZUMAB

  • UNII: P188ANX8CK
  • Preferred Substance Name: TRASTUZUMAB

  • 180288-69-1
  • 4D5V8
  • ABP980
  • ABP-980
  • ABP-980 (TRASTUZUMAB BIOSIMILAR)
  • BMAB-200
  • CANHERA
  • DMB-3111
  • DMB-3111 (TRASTUZUMAB BIOSIMILAR)
  • EG12014
  • EG-12014
  • EG-12014 (TRASTUZUMAB BIOSIMILAR)
  • EG12014 TRASTUZUMAB BIOSIMILAR
  • HERCEPTIN
  • HERCEPTIN HYLECTA COMPONENT TRASTUZUMAB
  • HERCESSI
  • HERZUMA
  • HLX02
  • HLX-02
  • HLX-02 TRASTUZUMAB BIOSIMILAR
  • IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL RHUMAB HER2(SUB .GAMMA.1)-CHAIN ANTIHUMAN P185(SUP C-ERBB2) RECEPTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB HER2 LIGHT CHAIN, DIMER
  • IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL RHUMAB HER2(SUB .GAMMA.1)-CHAIN ANTIHUMAN P185(SUP C-ERBB2) RECEPTOR), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB HER2 LIGHT CHAIN, DIMER
  • IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL RHUMAB HER2(SUB .GAMMA.1)-CHAIN ANTIHUMAN P185(SUP C-ERBB2) RECEPTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB HER2 LIGHT CHAIN, DIMER
  • IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL RHUMAB HER2(SUB .GAMMA.1)-CHAIN ANTIHUMAN P185(SUP C-ERBB2) RECEPTOR), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB HER2 LIGHT CHAIN, DIMER
  • KANJINTI
  • OGIVRI
  • ONTRUZANT
  • PF-05280014
  • PF-05280014 (TRASTUZUMAB BIOSIMILAR)
  • PHESGO COMPONENT TRASTUZUMAB
  • R-597
  • RHUMAB HER2
  • RHUMABHER2
  • RO0452317
  • RO-0452317
  • SB-3
  • SB-3 (TRASTUZUMAB BIOSIMILAR)
  • SYD977
  • SYD-977
  • TRASTUZUMAB (HERCEPTIN)
  • TRASTUZUMAB [EMA EPAR]
  • TRASTUZUMAB [INN]
  • TRASTUZUMAB [JAN]
  • TRASTUZUMAB [MART.]
  • TRASTUZUMAB [MI]
  • TRASTUZUMAB [PURPLE BOOK CDER]
  • TRASTUZUMAB [USAN]
  • TRASTUZUMAB [VANDF]
  • TRASTUZUMAB [WHO-DD]
  • TRASTUZUMAB ANNS [WHO-DD]
  • TRASTUZUMAB BETA
  • TRASTUZUMAB BETA [INN]
  • TRASTUZUMAB BIOSIMILAR (ABP-980)
  • TRASTUZUMAB BIOSIMILAR (AMGEN)
  • TRASTUZUMAB BIOSIMILAR (CELLTRION)
  • TRASTUZUMAB BIOSIMILAR (CT-P6)
  • TRASTUZUMAB BIOSIMILAR (MYL-1401O)
  • TRASTUZUMAB BIOSIMILAR (MYLAN GMBH)
  • TRASTUZUMAB BIOSIMILAR (PFIZER)
  • TRASTUZUMAB BIOSIMILAR (SB-3)
  • TRASTUZUMAB DKST [WHO-DD]
  • TRASTUZUMAB DTTB [WHO-DD]
  • TRASTUZUMAB PKRB [WHO-DD]
  • TRASTUZUMAB QYYP [WHO-DD]
  • TRASTUZUMAB, LICENSE HOLDER UNSPECIFIED
  • TRASTUZUMAB-ANNS
  • TRASTUZUMAB-DKST
  • TRASTUZUMAB-DKST [PURPLE BOOK CDER]
  • TRASTUZUMAB-DTTB
  • TRASTUZUMAB-DTTB [PURPLE BOOK CDER]
  • TRASTUZUMAB-OYSK
  • TRASTUZUMAB-PKRB
  • TRASTUZUMAB-PKRB [PURPLE BOOK CDER]
  • TRASTUZUMAB-QYYP
  • TRASTUZUMAB-STRF
  • TRASTUZUMAB-ZZXF
  • TRAZIMERA
  • ZERCEPAC

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.




About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

Powered by

DNAnexus official logo